Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care.

Payne RA, Abel GA, Avery AJ, Mercer SW, Roland MO.

Br J Clin Pharmacol. 2014 Jun;77(6):1073-82. doi: 10.1111/bcp.12292.

2.

Cardiovascular polypharmacy is not associated with unplanned hospitalisation: evidence from a retrospective cohort study.

Appleton SC, Abel GA, Payne RA.

BMC Fam Pract. 2014 Mar 31;15:58. doi: 10.1186/1471-2296-15-58.

3.

The effect of physical multimorbidity, mental health conditions and socioeconomic deprivation on unplanned admissions to hospital: a retrospective cohort study.

Payne RA, Abel GA, Guthrie B, Mercer SW.

CMAJ. 2013 Mar 19;185(5):E221-8. doi: 10.1503/cmaj.121349. Epub 2013 Feb 19.

4.

Prevalence of polypharmacy in a Scottish primary care population.

Payne RA, Avery AJ, Duerden M, Saunders CL, Simpson CR, Abel GA.

Eur J Clin Pharmacol. 2014 May;70(5):575-81. doi: 10.1007/s00228-013-1639-9. Epub 2014 Feb 1.

PMID:
24487416
5.

Using electronic medical record data to characterize the level of medication use by age-groups in a network of primary care clinics.

Freund J, Meiman J, Kraus C.

J Prim Care Community Health. 2013 Oct;4(4):286-93. doi: 10.1177/2150131913495243. Epub 2013 Jul 8.

PMID:
24327665
6.

Primary Care Medication Safety Surveillance with Integrated Primary and Secondary Care Electronic Health Records: A Cross-Sectional Study.

Akbarov A, Kontopantelis E, Sperrin M, Stocks SJ, Williams R, Rodgers S, Avery A, Buchan I, Ashcroft DM.

Drug Saf. 2015 Jul;38(7):671-82. doi: 10.1007/s40264-015-0304-x.

7.

Prescribing patterns and predictors of high-level polypharmacy in the elderly population: A prospective surveillance study from two teaching hospitals in India.

Harugeri A, Joseph J, Parthasarathi G, Ramesh M, Guido S.

Am J Geriatr Pharmacother. 2010 Jun;8(3):271-80. doi: 10.1016/j.amjopharm.2010.06.004.

PMID:
20624616
8.

Polypharmacy and Unplanned Hospitalizations in Patients with Rheumatoid Arthritis.

Filkova M, Carvalho J, Norton S, Scott D, Mant T, Molokhia M, Cope A, Galloway J.

J Rheumatol. 2017 Dec;44(12):1786-1793. doi: 10.3899/jrheum.160818. Epub 2017 Oct 1.

PMID:
28966210
9.

Investigating polypharmacy and drug burden index in hospitalised older people.

Best O, Gnjidic D, Hilmer SN, Naganathan V, McLachlan AJ.

Intern Med J. 2013 Aug;43(8):912-8. doi: 10.1111/imj.12203.

PMID:
23734965
10.

Polypharmacy and hospitalization among older home care patients.

Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE.

J Gerontol A Biol Sci Med Sci. 2000 Oct;55(10):M554-9.

PMID:
11034227
11.

Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?

Calderón-Larrañaga A, Poblador-Plou B, González-Rubio F, Gimeno-Feliu LA, Abad-Díez JM, Prados-Torres A.

Br J Gen Pract. 2012 Dec;62(605):e821-6. doi: 10.3399/bjgp12X659295.

12.

Review of prescription medications in home-based older adults with stroke: a pilot study.

Classen S, Meuleman J, Garvan C, Ried LD, Mann W, Asal N.

Res Social Adm Pharm. 2007 Mar;3(1):104-22.

PMID:
17350560
13.

Medication prescription among elderly patients admitted through an acute assessment unit.

Yong TY, Lau SY, Li JY, Hakendorf P, Thompson CH.

Geriatr Gerontol Int. 2012 Jan;12(1):93-101. doi: 10.1111/j.1447-0594.2011.00737.x. Epub 2011 Sep 19.

PMID:
21929721
14.

Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia.

Hoffmann F, van den Bussche H, Wiese B, Schön G, Koller D, Eisele M, Glaeske G, Scherer M, Kaduszkiewicz H.

BMC Psychiatry. 2011 Dec 6;11:190. doi: 10.1186/1471-244X-11-190.

15.

Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.

Lai HY, Hwang SJ, Chen YC, Chen TJ, Lin MH, Chen LK.

Clin Ther. 2009 Aug;31(8):1859-70. doi: 10.1016/j.clinthera.2009.08.023.

PMID:
19808145
16.

Assessment of a safety enhancement to the hospital medication reconciliation process for elderly patients.

Gizzi LA, Slain D, Hare JT, Sager R, Briggs F 3rd, Palmer CH.

Am J Geriatr Pharmacother. 2010 Apr;8(2):127-35. doi: 10.1016/j.amjopharm.2010.03.004.

PMID:
20439062
17.

Potentially inappropriate medication prescribing in outpatient practices: prevalence and patient characteristics based on electronic health records.

Buck MD, Atreja A, Brunker CP, Jain A, Suh TT, Palmer RM, Dorr DA, Harris CM, Wilcox AB.

Am J Geriatr Pharmacother. 2009 Apr;7(2):84-92. doi: 10.1016/j.amjopharm.2009.03.001.

PMID:
19447361
18.

Polypharmacy among inpatients aged 70 years or older in Australia.

Hubbard RE, Peel NM, Scott IA, Martin JH, Smith A, Pillans PI, Poudel A, Gray LC.

Med J Aust. 2015 Apr 20;202(7):373-7.

PMID:
25877120
19.

Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.

Hanlon P, Nicholl BI, Jani BD, McQueenie R, Lee D, Gallacher KI, Mair FS.

BMJ Open. 2018 Jan 14;8(1):e018404. doi: 10.1136/bmjopen-2017-018404.

20.

General practitioners' views on polypharmacy and its consequences for patient health care.

Köberlein J, Gottschall M, Czarnecki K, Thomas A, Bergmann A, Voigt K.

BMC Fam Pract. 2013 Aug 15;14:119. doi: 10.1186/1471-2296-14-119.

Supplemental Content

Support Center